PQ Bypass is a medical device company, which aims to transform the treatment of long-segment femoropopliteal disease. The Company's products include Detour System, a novel approach to fully-percutaneous femoral-popliteal bypass; PQ Snare, an over-the-wire, dual-nitinol-caged endovascular scaffold created to present a destination and snare for guidewires; PQ Crossing Device, a spring-loaded guidewire support and delivery system; and TORUS Stent Graft System, which features a self-expanding composite structure.
|Employees (est.) (Nov 2019)||31||(+7%)|
PQ Bypass total Funding
PQ Bypass latest funding size
Time since last funding
|10 months ago|
PQ Bypass investors
|Deerfield Capital Management, Seroba Life Sciences, MedTech Venture Partners|
PQ Bypass has 481 Twitter Followers. The number of followers has increased 7.2% month over month and increased 12.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was PQ Bypass founded?
PQ Bypass was founded in 2009.
How many employees does PQ Bypass have?
PQ Bypass has 31 employees.
Who are PQ Bypass competitors?
Competitors of PQ Bypass include Mevion Medical Systems, EBR Systems and Inspire Medical Systems.
Where is PQ Bypass headquarters?
PQ Bypass headquarters is located at 1971 Milmont Dr, Milpitas.
Where are PQ Bypass offices?
PQ Bypass has an office in Milpitas.
How many offices does PQ Bypass have?
PQ Bypass has 1 office.
Receive alerts for 300+ data fields across thousands of companies